AB Science provides update on masitinib programs timelines

Ads

You May Also Like

AnaptysBio Announces First-In-Human Dosing of ANB019

SAN DIEGO, April 06, 2017 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology ...